Christopher Moreau - Net Worth and Insider Trading
Christopher Moreau Net Worth
The estimated net worth of Christopher Moreau is at least $92,140 dollars as of 2024-09-21. Christopher Moreau is the Director, Senior Officer of Algernon Pharmaceuticals Inc and owns about 1,084,002 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $92,140. Details can be seen in Christopher Moreau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Moreau has not made any transactions after 2024-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Moreau
Christopher Moreau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Moreau owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Christopher Moreau’s form 4 insider trades.
Insider Ownership Summary of Christopher Moreau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-06-05 | Director & Senior Officer |
Christopher Moreau Latest Holdings Summary
Christopher Moreau currently owns a total of 1 stock. Christopher Moreau owns 1,084,002 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of June 5, 2024, with a value of $92,140.
Latest Holdings of Christopher Moreau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-06-05 | 1,084,002 | 0.09 | 92,140 |
Holding Weightings of Christopher Moreau
Christopher Moreau Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Moreau has made a total of 17 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 17 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 2,500 shares on June 5, 2024, which cost Christopher Moreau around $350.
Insider Trading History of Christopher Moreau
- 1
Christopher Moreau Trading Performance
GuruFocus tracks the stock performance after each of Christopher Moreau's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Moreau is 42.88%. GuruFocus also compares Christopher Moreau's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Moreau within 3 months outperforms 12 times out of 18 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Moreau's insider trading performs compared to the benchmark.
Performance of Christopher Moreau
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30 | | | | | |
| Relative Return to S&P 500(%) | 30.41 | | | | | |
Christopher Moreau Ownership Network
Christopher Moreau Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Christopher Moreau is the Director & Senior Officer of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Senior Officer Christopher Scott Bryan , Senior Officer James Kinley , and Senior Officer Michael Sadhra .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Christopher Moreau made 3 insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN) with a net purchase of 52,500. Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 60,500 shares made by Christopher Scott Bryan , a net purchase of 12,500 shares made by James Kinley ,
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 125,500 shares were bought by its insiders, resulting in a net purchase of 125,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Christopher Moreau Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Moreau. Currently GuruFocus does not have mailing address information for Christopher Moreau.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
